Tech Company Financing Transactions
AskGene Pharma Funding Round
On 5/9/2022, AskGene Pharma landed $20 million in Series A funding from Qiming Ventures and TF Capital.
Transaction Overview
Company Name
Announced On
5/9/2022
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Qiming Ventures (Lead Investor)
TF Capital (Lead Investor)
Proceeds Purpose
Proceeds from the financing will be used to advance clinical development of its pipeline of innovative therapeutic candidates and development of SmartKine® cytokine prodrug platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5217 Verdugo Way A
Camarillo, CA 93012
USA
Camarillo, CA 93012
USA
Phone
Website
Email Address
Overview
At AskGene Pharma, we have a clear mission: to apply our breakthrough SmartKine® platform technology to unlock the full therapeutic potential of cytokines with better safety profiles.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jian-Feng Lu
Chief Scientific Officer
Yuefeng Lu
Browse more venture capital transactions:
Prev: 5/9/2022: Pyramid Analytics venture capital transaction
Next: 5/10/2022: Genascence venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs